Literature DB >> 26404111

Cervical HPV infection in Romanian women infected with HIV during early childhood.

Luminita Ene1, Cristina Voinea1, Claudia Stefanescu1, Diana Sima1, Dan Duiculescu2, Sanjay R Mehta3.   

Abstract

Human papillomavirus (HPV) is the most common cause of cervical cancer worldwide, and Romania has the highest rate of cervical cancer in Europe. Sixty-five young Romanian women infected with HIV during early childhood and 25 control subjects were evaluated for the presence of cervical HPV infection and for cytologic abnormalities. HPV infection was evaluated longitudinally in 42 HIV-infected individuals. Overall 28/65 (43.1%) of HIV-infected and 8/25 (32.0%) of uninfected subjects were infected with HPV, and 21/65 (32.3%) and 6/25 (24%) had high-risk subtypes, respectively. In HIV-infected women, those maintaining or acquiring a new subtype in follow-up were more likely to have a lower nadir (p = 0.04) and current (p = 0.01) CD4 cell counts. The incidence rate for HPV acquisition events was 0.69 per subject per year, and 0.52 for high-risk subtypes. In the HIV-infected group, 9/13 (69.2%) individuals with abnormal cytology progressed at follow-up. Although HPV prevalence was similar to controls, the rate of Pap smear abnormalities was much higher, possibly due to the decreased ability to mount new immune responses. Given the high rate of incident detection of vaccine preventable strains and cytologic progression in this cohort, HPV vaccination may be beneficial at any age in co-infected women.
© The Author(s) 2016.

Entities:  

Keywords:  HIV; HPV; Human papilloma virus; Romania; cervical dysplasia; vaccination; women

Mesh:

Year:  2015        PMID: 26404111      PMCID: PMC5482901          DOI: 10.1177/0956462415608333

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  30 in total

1.  Prevalence and risk factors for anal squamous intraepithelial lesions in women.

Authors:  E A Holly; M L Ralston; T M Darragh; R M Greenblatt; N Jay; J M Palefsky
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

2.  Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women.

Authors:  Chunhui Wang; Thomas C Wright; Lynette Denny; Louise Kuhn
Journal:  J Infect Dis       Date:  2011-01-07       Impact factor: 5.226

3.  Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection.

Authors:  Ronald S Veazey; Preston A Marx; Andrew A Lackner
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

4.  International trends in incidence of cervical cancer: II. Squamous-cell carcinoma.

Authors:  A P Vizcaino; V Moreno; F X Bosch; N Muñoz; X M Barros-Dios; J Borras; D M Parkin
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

5.  Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; E A Holly; C J Hogeboom; M L Ralston; M M DaCosta; R Botts; J M Berry; N Jay; T M Darragh
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

6.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

Review 7.  Cervical and anal HPV infections in HIV positive women and men.

Authors:  Silvia de Sanjosé; Joel Palefsky
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

8.  The epidemic of human immunodeficiency virus infection in Romanian children.

Authors:  I V Patrascu; O Dumitrescu
Journal:  AIDS Res Hum Retroviruses       Date:  1993-01       Impact factor: 2.205

9.  HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.

Authors:  Karlhans F Che; Rachel L Sabado; Esaki M Shankar; Veronica Tjomsland; Davorka Messmer; Nina Bhardwaj; Jeffrey D Lifson; Marie Larsson
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

10.  HIV associated high-risk HPV infection among Nigerian women.

Authors:  Sally N Akarolo-Anthony; Maryam Al-Mujtaba; Ayotunde O Famooto; Eileen O Dareng; Olayinka B Olaniyan; Richard Offiong; Cosette M Wheeler; Clement A Adebamowo
Journal:  BMC Infect Dis       Date:  2013-11-05       Impact factor: 3.090

View more
  3 in total

1.  Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth.

Authors:  Annette H Sohn; Stephen J Kerr; Rawiwan Hansudewechakul; Sivaporn Gatechompol; Kulkanya Chokephaibulkit; Hanh Le Dung Dang; Dan Ngoc Hanh Tran; Jullapong Achalapong; Nipat Teeratakulpisarn; Amphan Chalermchockcharoenkit; Manopchai Thamkhantho; Tippawan Pankam; Thida Singtoroj; Wichai Termrungruanglert; Surasith Chaithongwongwatthana; Nittaya Phanuphak
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

2.  Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV-positive women attending public health centers in Addis Ababa city, Ethiopia.

Authors:  Saba Shiferaw; Adamu Addissie; Muluken Gizaw; Selamawit Hirpa; Wondimu Ayele; Sefonias Getachew; Eva J Kantelhardt; Mathewos Assefa; Ahmedin Jemal
Journal:  Cancer Med       Date:  2018-02-14       Impact factor: 4.452

3.  HPV and HIV Coinfection in Women from a Southeast Region of Romania-PICOPIV Study.

Authors:  Simona Claudia Cambrea; Mariana Aschie; Ghiulendan Resul; Anca Florentina Mitroi; Anca Chisoi; Antonela Anca Nicolau; Gabriela Izabela Baltatescu; Ana Maria Cretu; Gabriela Lupasteanu; Lucian Serbanescu; Mihaela Manea; Sebastian Theodor Topliceanu; Lucian Cristian Petcu; Loredana Pazara; Georgeta Camelia Cozaru
Journal:  Medicina (Kaunas)       Date:  2022-06-03       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.